• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ADVANCED STERILIZATION PRODUCTS CYCLESURE® BIO INDICATOR; INDICATOR, BIOLOGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ADVANCED STERILIZATION PRODUCTS CYCLESURE® BIO INDICATOR; INDICATOR, BIOLOGICAL Back to Search Results
Catalog Number 14324
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem Fever (1858)
Event Date 08/14/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
A customer reported a positive result with a cyclesure® 24 biological indicator (bi) after a completed sterrad® nx cycle.The bi was incubated for 24 hours.The chemical indicator (ci) changed color correctly.The previous and subsequent bi results were both negative.The affected load was released and used on two patients.There was no report of infection, injury or harm to the first patient associated with this issue.However, patient #2 reported to have a fever before the operation was performed and still had a fever post-operatively.No additional information is available regarding the patient.Based on the new information received, there is no potential serious injury reported that was related to an asp product.The patient had symptoms before the operation was performed and before the instruments were even used.However, advanced sterilization products (asp) has determined in this situation sterility cannot be assured and, as a matter of policy asp had decided to report all incidents of positive cyclesure® 24 biological indicators when the loads have been released for use without reprocessing.
 
Manufacturer Narrative
The investigation included a review of the device history record (dhr), trending of lot number, system risk analysis (sra), visual analysis and retains analysis.The dhr was reviewed and the involved lot met manufacturer specifications at the time of release.No anomalies were observed that would contribute to the customer's experienced issue.Trending analysis by lot number was reviewed for the previous six months and trending was not exceeded.The sra indicates the risk associated with exposure to biohazardous, pathogenic or infectious material is "low." the single cyclesure® 24 bi was not returned for visual inspection and further analysis.Thirty-two retains bis were subject to functional evaluation.All thirty-two bis met specification.The assignable cause could not be verified.It is unlikely the suspected positive bi was caused by a manufacturing issue as the retains met functional specification, dhr review found no anomalies that would contribute to a positive bi result and lot history review found trending was not exceeded in this lot.An issue with sterrad performance is also unlikely as the unit was serviced and no problem was found.A customer letter was sent regarding the user error of releasing the load for use without reprocessing first.The issue will continue to be tracked and trended.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CYCLESURE® BIO INDICATOR
Type of Device
INDICATOR, BIOLOGICAL
Manufacturer (Section D)
ADVANCED STERILIZATION PRODUCTS
33 technology drive
irvine CA 92618
MDR Report Key8051737
MDR Text Key126658007
Report Number2084725-2018-00754
Device Sequence Number1
Product Code FRC
UDI-Device Identifier10705037016211
UDI-Public10705037016211
Combination Product (y/n)N
PMA/PMN Number
K994055
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2019
Device Catalogue Number14324
Device Lot Number03218015
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/17/2018
Initial Date FDA Received11/08/2018
Supplement Dates Manufacturer Received12/06/2018
Supplement Dates FDA Received12/10/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
STERRAD® 100S (B)(4)
-
-